IQVIA Holdings Inc
ir.iqvia.comWhat Do They Do?
Provides outsourced clinical research and clinical-trial services to biopharmaceutical companies, alongside healthcare data and technology solutions and commercial services for life sciences and healthcare organizations.
10-K for FY2025, filed Feb 17, 2026We are managed through three reportable segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales &…View ↗
We have one of the largest and most comprehensive collections of healthcare information in the world spanning sales, prescription…View ↗
Health Care Provider Engagement Services. We partner with biopharmaceutical companies and other life sciences providers (e.g., medical…View ↗
How Do They Make Money?
Biopharmaceutical clients pay for clinical-trial services as the work progresses. Technology and information customers pay over subscriptions or when data is delivered, while project and sales-support services are paid for as work is performed.
10-K for FY2025, filed Feb 17, 2026The majority of the Company’s contracts within the Research & Development Solutions segment are service contracts for clinical research…View ↗
The Company derives the majority of its revenues in the Technology & Analytics Solutions segment from various information and technology…View ↗
The majority of revenues in the Company's Contract Sales & Medical Solutions segment is from contract sales force to the biopharmaceutical…View ↗
-
10-K for FY2025, filed Feb 17, 2026
FY2025 revenue by reportable segment ↗
$16.3B
-
10-K for FY2025, filed Feb 17, 2026
$16.3B ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Technology & Analytics Solutions
Mix
10-K for FY2025, filed Feb 17, 2026 |
41%
FY2022: 40%
|
Technology & Analytics Solutions, FY2025
$6.6B Sources
|
Mix |
|
Research & Development Solutions
Recurring
10-K for FY2025, filed Feb 17, 2026 |
55%
FY2022: 55%
|
Research & Development Solutions, FY2025
$8.9B Sources
|
Recurring |
|
Contract Sales & Medical Solutions
Recurring
|
4.8%
FY2022: 5.2%
|
Contract Sales & Medical Solutions, FY2025
$788M Sources
|
Recurring |
Who Are Their Customers?
Most sales are to life-sciences companies, including pharmaceutical and biotechnology businesses. Other customers include healthcare organizations and public agencies, with distributors and pharmacies also among the client base.
10-K for FY2025, filed Feb 17, 2026Sales to companies in life sciences, including pharmaceutical companies, biotechnology companies, device and diagnostic companies, and…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 8 cents of every revenue dollar as net income in FY2025 and turned 13 cents into free cash flow.
10-K for FY2025, filed Feb 17, 2026
$2.2BView ↗
10-K for FY2025, filed Feb 17, 2026
$1.4BView ↗
10-K for FY2025, filed Feb 17, 2026
$2.1BView ↗
How Are They Changing?
10-Q for Q2 FY2026, filed Jul 28, 2026
Open tableView ↗
-
Jul 28, 2026
Raised full-year guidance for revenue and adjusted earnings
Sources
8-K, filed Jul 28, 2026
To reflect stronger organic revenue growth, and changes in the M&A and foreign exchange impacts, the company is raising its full-year 2026…View ↗
Growing. Revenue grew 18% in 4 years, from $13.9B in FY2021 to $16.3B in FY2025, about 4% a year.
Who Do They Compete With?
Competes with Accenture, Aetion, Panalgo, Cognizant Technology Solutions, Deloitte, Thermo Fisher Scientific, Relx, IBM, Infosys, Oracle Health, McKinsey, NielsenIQ, UnitedHealth Group, Parexel International, Press Ganey, RTI Health Solutions, ICON, Definitive Healthcare, Cegedim, and Tempus
10-K for FY2025, filed Feb 17, 2026Our Technology & Analytics Solutions business competes with a broad and diverse set of businesses. While we believe no competitor provides…View ↗
Loading...
